HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

In Brief: Revlon reducing Parlux stake

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Revlon reducing Parlux stake: Revlon now holds a 2.1% stake in Parlux Fragrances after selling 365,000 Parlux shares between April 24 and April 29 for about $4 mil., according to a 13D filed May 1 with the Securities and Exchange Commission. Revlon received a 5.4% stake (600,000 shares) in Parlux as partial payment for the Alexandra de Markoff brand in January. In a 13D filed April 12, Revlon had said it planned to sell its stake in Parlux on the open market ("The Rose Sheet" April 22, In Brief)...

Table

View full table

Tags:
Latest Headlines

Beauty Firms Should Draft AI Use Policies, Even If They Don’t Plan To Use AI – Attorney

Supreme Court To Hear RICO Complaint Against CBD Firms As Hemp Regulation Remains AWOL

Nestlé Joins Forces With Dr Reddy’s In India To Grow Dietary Supplements Reach

Partisan Politics Returns To US FDA Congressional Oversight

See All
UsernamePublicRestriction

Register

RS002804

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By